3136 results for «2651»

Filter By

3136 results

Primary mitral regurgitation edge to edge repair with one device - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.

LIVE case from Sendai Kousei Hospital - Sendai, Japan

 
Navigate the video by moving your mouse over the chapter icon in...

Mitral transcatheter edge to edge repair for a patient with degenerative mitral regurgitation - LIVE case

Shaping the future of structural heart disease intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Shaping the future of structural heart disease intervention

Rapid-fire - Mitral TEER for special situations

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session

TAVI and future coronary access - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

TAVI and future coronary access - LIVE case

PCR Tokyo Valves 2024 Closing Ceremony

18 Feb 2024 – From PCR Tokyo Valves 2024

The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...

PCR Tokyo Valves 2024

TAV-in-TAV interventions: a new frontier in TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...

TAV-in-TAV interventions:

Heart Team in action: managing complex cases together

17 Feb 2024 – From PCR Tokyo Valves 2024

In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments. 

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

Plan your moves: strategies for valves re-intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...

CAD and TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...

CAD and TAVI

Facilitating coronary access after TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.

TEER for primary mitral regurgitation

18 Feb 2024 – From PCR Tokyo Valves 2024

What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...

TEER for primary mitral regurgitation

TAVI optimisation

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...

TAVI optimisation

Managing aortic stenosis in patients with longer life expectancy

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.

Tricuspid valve interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.

Tricuspid valve interventions

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Rapid-fire - Mitral TEER for complex situations

18 Feb 2024 – From PCR Tokyo Valves 2024

This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!

Ultra-low contrast PCI - An indispensable toolset in complex coronary interventions and higher-risk patients

17 May 2023 – From EuroPCR 2023

Discover the indispensable toolset of ultra-low contrast (ULC) percutaneous coronary intervention (PCI) in complex coronary interventions and higher-risk patients in this session. Gain a comprehensive understanding of how ULC PCI can enhance the safety and quality of revascularization in complex procedures and learn practical aspects from...

Ultra-low contrast PCI

How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor

17 May 2023 – From EuroPCR 2023

Discover the optimal approach to peri-percutaneous coronary intervention (PCI) antiplatelet treatment in clinical practice with a focus on the novel agent cangrelor. Gain a deeper understanding of the rationale behind cangrelor's use in various PCI settings, learn about the current recommendations and practices for its administration...

How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor
Didn’t find what you were looking for?